Please ensure Javascript is enabled for purposes of website accessibility

Why Sanderson Farms, Valeant Pharmaceuticals International, and Criteo Slumped Today

By Dan Caplinger - Dec 14, 2017 at 4:44PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Find out the latest company that mentioned the NFL's impact on its business.

Wall Street finally gave up some ground on Thursday, as the Dow Jones Industrials finished down more than 75 points. Major benchmarks generally posted modest losses of half a percent or less as investors continued to get pulled in both directions by political wrangling in Washington. Tax reform now appears to have a path to full approval, but at least a few lawmakers voiced their dissent for certain provisions that made it into the final compromise proposal. Moreover, some bad news from individual companies spoiled the market's previously positive tone. Sanderson Farms (SAFM -1.41%), Valeant Pharmaceuticals International (BHC -1.76%), and Criteo (CRTO 1.46%) were among the worst performers on the day. Below, we'll look more closely at these stocks to tell you why they did so poorly.

Sanderson sees slumping wing prices

Shares of Sanderson Farms fell 13% after the meat producer reported its fiscal fourth-quarter financial results. The producer of chicken and other meats said that sales climbed 16% from the year-ago quarter, but net income fell slightly over the same period. CEO Joe Sanderson Jr. said that the quarter marked "the end of another record year for Sanderson Farms" but that hurricane disruptions made a typical seasonal decrease in demand worse. The CEO also noted that some of its customers have told the company that traffic is down because of NFL player demonstrations, although competitors' substitutes for traditional chicken wings could also be having an impact on overall performance.

Plate of fried chicken with a dark red-brown sauce in the middle.

Image source: Sanderson Farms.

Valeant gets smacked with a downgrade

Valeant Pharmaceuticals International stock dropped 11% in the wake of negative comments from Wall Street analysts. The pharma company's shares got downgraded from neutral to underweight by JPMorgan, whose analysts argued that the future loss of patent protection on key drugs might make current valuations suspect. Although Valeant has done a good job of paying down some of its debt, it still faces a considerable load that could make it tougher to maintain, especially if the Federal Reserve continues with interest rate increases over the next couple of years. Without pipeline success, Valeant could face tough times in the near future.

Criteo deals with ad blockers

Finally, shares of Criteo plunged 23%. The advertising technology company provided an update on its outlook for the fourth quarter, saying that revenue could see a negative impact from recent moves by Apple to strengthen its ad-tracking prevention system. The latest version of the iOS operating system disables a method that Criteo had previously used for the Safari browser, and although Criteo had already anticipated some downward impact from the move, it will now have to develop long-term alternatives to find a workaround. Until things play out a bit more, Criteo will be flying blind in trying to determine just how big a hit it will take.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Bausch Health Companies Inc. Stock Quote
Bausch Health Companies Inc.
BHC
$8.36 (-1.76%) $0.15
Sanderson Farms, Inc. Stock Quote
Sanderson Farms, Inc.
SAFM
$215.53 (-1.41%) $-3.08
Criteo S.A. Stock Quote
Criteo S.A.
CRTO
$24.40 (1.46%) $0.35

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
317%
 
S&P 500 Returns
112%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 07/01/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.